Comment on: Consolidation treatment for high risk solid tumors in children with myeloablative chemotherapy and autologous hematopoietic progenitor stem cell transplantation
- PMID: 24255610
- PMCID: PMC3832307
- DOI: 10.5581/1516-8484.20130104
Comment on: Consolidation treatment for high risk solid tumors in children with myeloablative chemotherapy and autologous hematopoietic progenitor stem cell transplantation
Conflict of interest statement
Conflict-of-interest disclosure: The author declares no competing financial interest
Comment on
- Consolidation treatment for high risk solid tumors in children with myeloablative chemotherapy and autologous hematopoietic progenitor stem cell transplantation. :343–346.
References
-
- Matthay KK, Reynolds CP, Seeger RC, Shimada H, Adkins ES, Hass-Kogan D, et al. Long term results for children with high risk neuroblastoma treated won a randomized trial of myeloablative therapy followed by 13-cis retinoic acid: a children's oncology group study. J Clin Oncol. 2009;27(7):1007–1013. - PMC - PubMed
-
- Campbell AD, Cohn SL, Reynolds M, Seshadri R, Morgan E, Geissler G, et al. Treatment of relapsed Wilms tumor with high dose therapy and autologous hematopoietic stem cell rescue, the experience at Children's Memorial Hospital. J Clin Oncol. 2004;22(14):2885–2890. - PubMed
-
- Agarwal R, Dvorak CC, Stockerl-Goldstein KE, Johnston L, Srinivas S. Highdose chemotherapy followed by stem cell rescue for highrisk germ cell tumors: the Stanford experience. Bone Marrow Transplant. 2009;43(7):547–552. - PubMed
-
- Burke MJ, Walterhouse DO, Jacobsohn DA, Duerst RE, Kletzel M. Tandem highdose chemotherapy with autologous peripheral hematopoietic progenitor cell rescue as consolidation therapy for patients with highrisk Ewing family tumors. Pediatr Blood Cancer. 2007;49(2):196–198. Comment in: Pediatr Blood Cancer. 2007;49(2):115-6. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources